{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:41:04Z","timestamp":1790700064647,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T00:00:00Z","timestamp":1684886400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013885","name":"Government of Malaysia Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013885","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.heliyon.2023.e16652","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T01:06:15Z","timestamp":1685495175000},"page":"e16652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Effects of one-year supplementation with Phyllanthus niruri on fibrosis score and metabolic markers in patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial"],"prefix":"10.1016","volume":"9","author":[{"given":"Muhammad Radzi","family":"Abu Hassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaida","family":"Hj Md Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zalwani","family":"Zainuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haniza","family":"Omar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siti Maisarah","family":"Md Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siti Aishah","family":"Aris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6710-7257","authenticated-orcid":false,"given":"Huan-Keat","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.heliyon.2023.e16652_bib1","doi-asserted-by":"crossref","first-page":"715","DOI":"10.4254\/wjh.v9.i16.715","article-title":"Non-alcoholic fatty liver disease: an expanded review","volume":"9","author":"Benedict","year":"2017","journal-title":"World J. Hepatol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e16652_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.heliyon.2023.e16652_bib3","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13098-020-00570-y","article-title":"NAFLD as a continuum: from obesity to metabolic syndrome and diabetes","volume":"12","author":"Godoy-Matos","year":"2020","journal-title":"Diabetol. Metab. Syndrome"},{"issue":"10","key":"10.1016\/j.heliyon.2023.e16652_bib4","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/oby.22964","article-title":"A fad too far? Dietary strategies for the prevention and treatment of NAFLD","volume":"28","author":"Moore","year":"2020","journal-title":"Obesity"},{"issue":"30","key":"10.1016\/j.heliyon.2023.e16652_bib5","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.3748\/wjg.v24.i30.3361","article-title":"Current guidelines for the management of non-alcoholic fatty liver disease: a systematic review with comparative analysis","volume":"24","author":"Leoni","year":"2018","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e16652_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/cts.12839","article-title":"Evolving role for pharmacotherapy in NAFLD\/NASH","volume":"14","author":"Attia","year":"2021","journal-title":"Clin. Transl. Sci."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e16652_bib7","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/jphp.12565","article-title":"The pharmacological potential of Phyllanthus niruri","volume":"68","author":"Lee","year":"2016","journal-title":"J. Pharm. Pharmacol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e16652_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226185","article-title":"In-depth hepatoprotective mechanistic study of Phyllanthus niruri: in vitro and in vivo studies and its chemical characterization","volume":"15","author":"Ezzat","year":"2020","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e16652_bib9","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.fct.2006.10.029","article-title":"Protein isolate from the herb, Phyllanthus niruri L. (Euphorbiaceae), plays hepatoprotective role against carbon tetrachloride induced liver damage via its antioxidant properties","volume":"45","author":"Bhattacharjee","year":"2007","journal-title":"Food Chem. Toxicol."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e16652_bib10","first-page":"514","article-title":"Effect of Phyllanthus niruri Linn. treatment on liver, kidney and testes in CCl4 induced hepatotoxic rats","volume":"46","author":"Manjrekar","year":"2008","journal-title":"Indian J. Exp. Biol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e16652_bib11","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1073\/pnas.84.1.274","article-title":"Effects of an extract from Phyllanthus niruri on hepatitis B and woodchuck hepatitis viruses: in vitro and in vivo studies","volume":"84","author":"Venkateswaran","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"12","key":"10.1016\/j.heliyon.2023.e16652_bib12","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1211\/jpp.58.12.0001","article-title":"Phytochemicals from Phyllanthus niruri Linn. and their pharmacological properties: a review","volume":"58","author":"Bagalkotkar","year":"2006","journal-title":"J. Pharm. Pharmacol."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e16652_bib13","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3109\/19390211.2010.522553","article-title":"The anti-inflammatory and antinociceptive properties of the chloroform fraction from Phyllanthus niruri plant is mediated via the peripheral nervous system","volume":"7","author":"Obidike","year":"2010","journal-title":"J. Diet. Suppl."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e16652_bib14","first-page":"299","article-title":"Hepatoprotective effect of aqueous extract of Phyllanthus niruri on nimesulide-induced oxidative stress in vivo","volume":"43","author":"Chatterjee","year":"2006","journal-title":"Indian J. Biochem. Biophys."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e16652_bib15","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/ptr.1933","article-title":"The protein fraction of Phyllanthus niruri plays a protective role against acetaminophen induced hepatic disorder via its antioxidant properties","volume":"20","author":"Bhattacharjee","year":"2006","journal-title":"Phytother Res."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e16652_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/nu9070766","article-title":"Phyllanthus niruri standardized extract alleviates the progression of non-alcoholic fatty liver disease and decreases atherosclerotic risk in Sprague-Dawley rats","volume":"9","author":"Al Zarzour","year":"2017","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e16652_bib17","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1159\/000484927","article-title":"Phyllanthus niruri versus placebo for chronic hepatitis B virus infection: a randomized controlled trial","volume":"25","author":"Baiguera","year":"2018","journal-title":"Complement. Med. Res."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e16652_bib18","doi-asserted-by":"crossref","first-page":"448","DOI":"10.4103\/ijp.IJP_540_20","article-title":"Efficacy of Phyllanthus niruri on improving liver functions in patients with alcoholic hepatitis: a double-blind randomized controlled trial","volume":"53","author":"Sowjanya","year":"2021","journal-title":"Indian J. Pharmacol."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e16652_bib19","article-title":"Efficacy and safety of Phyllanthus niruri in non-alcoholic steatohepatitis treatment: pilot study from Malaysia","volume":"3","author":"Hassan","year":"2017","journal-title":"J. Pharm. Pract. Commun. Med."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e16652_bib20","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2478\/v10102-011-0031-9","article-title":"Acute toxicity studies of aqueous leaf extract of Phyllanthus niruri","volume":"4","author":"Asare","year":"2011","journal-title":"Interdiscipl. Toxicol."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e16652_bib21","first-page":"1","article-title":"Interpretation of animal dose and human equivalent dose for drug development","volume":"31","author":"Shin","year":"2010","journal-title":"J. Korean Med."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e16652_bib22","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1053\/j.gastro.2008.03.078","article-title":"Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled fatty liver improvement with rosiglitazone therapy (FLIRT) trial","volume":"135","author":"Ratziu","year":"2008","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e16652_bib24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.15403\/jgld.2014.1121.252.cap","article-title":"Effect of short-term vitamin D correction on hepatic steatosis as quantified by controlled attenuation parameter (CAP)","volume":"25","author":"Papapostoli","year":"2016","journal-title":"J. Gastrointest. Liver Dis."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e16652_bib25","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12876-017-0652-3","article-title":"Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study","volume":"17","author":"Honda","year":"2017","journal-title":"BMC Gastroenterol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e16652_bib26","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3346\/jkms.2017.32.1.60","article-title":"Lobeglitazone, a novel thiazolidinedione, improves non-alcoholic fatty liver disease in type 2 diabetes: its efficacy and predictive factors related to responsiveness","volume":"32","author":"Lee","year":"2017","journal-title":"J. Kor. Med. Sci."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e16652_bib27","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.34897","article-title":"Ginger supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study","volume":"16","author":"Rahimlou","year":"2016","journal-title":"Hepat. Mon."},{"key":"10.1016\/j.heliyon.2023.e16652_bib28","series-title":"A Prospective Study to Evaluate the Efficacy of a Standardized Low Calorie Diet According to PNPLA3 Genotype in Patients with Non Alcoholic Fatty Liver Disease (NAFLD)\u20132 Months Data (Interim Analysis). Hepatology","first-page":"588A","author":"Teufelhart","year":"2016"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e16652_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/nu13010066","article-title":"Physical activity and low glycemic index Mediterranean diet: main and modification effects on NAFLD score. Results from a randomized clinical trial","volume":"13","author":"Franco","year":"2020","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e16652_bib30","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1373\/clinchem.2006.081257","article-title":"Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease","volume":"53","author":"Chang","year":"2007","journal-title":"Clin. Chem."},{"issue":"39","key":"10.1016\/j.heliyon.2023.e16652_bib31","doi-asserted-by":"crossref","first-page":"5919","DOI":"10.3748\/wjg.v26.i39.5919","article-title":"Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease","volume":"26","author":"Campos-Murgu\u00eda","year":"2020","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e16652_bib32","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/j.clinre.2015.06.015","article-title":"Reversibility of liver fibrosis","volume":"39","author":"Sun","year":"2015","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"14","key":"10.1016\/j.heliyon.2023.e16652_bib33","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1097\/CM9.0000000000000835","article-title":"Regression of liver fibrosis: evidence and challenges","volume":"133","author":"Sun","year":"2020","journal-title":"Chin. Med. J."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e16652_bib34","doi-asserted-by":"crossref","first-page":"377","DOI":"10.4254\/wjh.v7.i3.377","article-title":"Angiogenesis and liver fibrosis","volume":"7","author":"Elpek","year":"2015","journal-title":"World J. Hepatol."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e16652_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/nu10081057","article-title":"Adipocytokine regulation and antiangiogenic activity underlie the molecular mechanisms of therapeutic effects of Phyllanthus niruri against non-alcoholic fatty liver disease","volume":"10","author":"Zarzour","year":"2018","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e16652_bib36","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1159\/000484927","article-title":"Phyllanthus niruri versus placebo for chronic hepatitis B virus infection: a randomized controlled trial","volume":"25","author":"Baiguera","year":"2018","journal-title":"Complement. Med. Res."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e16652_bib37","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jhep.2021.04.044","article-title":"Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis","volume":"75","author":"Selvaraj","year":"2021","journal-title":"J. Hepatol."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023038598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023038598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:28:55Z","timestamp":1790468935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023038598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S2405844023038598"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e16652","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of one-year supplementation with Phyllanthus niruri on fibrosis score and metabolic markers in patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e16652","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e16652"}}